ABSTRACT. al-Antichymotrypsin (al-ACHY) and al-an-(I). al-AT and aI-ACHY play major roles in the host response titrypsin (al-AT) are closely related glycoprotein protease to trauma and inflammation. The major function of aI-AT, inhibitors, present in plasma and other extracellular fluids, which is present at high levels in human plasma (1 5 3 . 5 mg/ that neutralize proteases released by leukocytes in re-mL), is to inhibit elastases released by leukocytes at sites of sponse to trauma and inflammatory stimuli. Both inhibitors inflammation. al-ACHY, present in plasma at lower levels (0.3-are synthesized primarily by hepatocytes, although lower 0.6 mg/mL), is thought to neutralize ch~motry~sin-like Proteases levels of synthesis by monocytes and breast and intestinal S U C~ aS cathepsin G also released by leukocytes at inflammatory epithelial cells have been demonstrated. Recently, the im-sites. a,-ACHY and (UI-AT belong to the serpin supergene family m u n o~i s t o c~e m i c a~ localization of a l -~~ and aI-~~-~~ in as does CBG, the major glucocorticoid camer in the circulation intrauterine and extrauterine human trophoblastic tissue (2). CBG is cleaved by elastase at a unique site in its C-terminal has been reported.
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the present study, we have sought to region resulting in decreased glucocorticoid binding (3) . Because determine whether human trophoblast is also able to syn-local elastase levels depend to a large degree on local levels of althesize al-AT and
Messenger RNA for both AT, delivery of glucocorticoids to inflammatory sites may be inhibitors was found by Northern blotting in chorionic villi regulated by a mechanism involving the interaction of elastase and aI-AT. obtained from first trimester and term placenta. SubstanaI-AT and are synthesized primarily by hepatocytes tial differences in messenger levels for both inhibitors and to a lesser degree by monocytes (4). We have shown that among individual placentas were noted' al-ACHY and al-MCF-7 human breast cancer cells, a cell line of epithelial AT messenger was present in trophoblast in can also synthesize these protease inhibitors and that their synprimary culture. Synthesis of al-AT and al-ACHY protein thesis can be stimulated by steroid hormones, cytokines, and was demonstrated by SDS-PAGE after immuno~reci~ita-growth factors (5) . ~l t h o u g h the amount of al-AT and aI-ACHY tion of 135S1-labeled ~I -A T and a]-ACHY from conditioned produced by nonhepatic cells is small in comparison to that media of trophoblast cells in culture metabolically labeled by hepatocytes, local synthesis may be important at with [35S]-methionine. It is of some interest that the M, of sites of inflammation, particularly at locations not directly in the al-AT and ffl-ACHY secreted by trophob1ast contact with the circulation where levels of al-AT and aI-ACHY 50 000 and 49 000, respectively, compared with 54 000 and may only be a fraction of that in plasma (6) . Implantation of the 6 8 000 for these proteins in plasma (or secreted by H~P G~ embryo in the uterus elicits an inflammatory response, the human hepatoma and MCF-7 human breast cancer cells). control of which is required for normal implantation and placenAfter enzymatic deglycosylation, the M, of the a -A T and tation (7) . Local synthesis of serpins may be necessary to control al-ACHY secreted by trophoblast and HepG2 cells were the maternal inflammatory response to invasion by trophoblast. all approximately 46 000, suggesting incomplete glycosyl-Abnormal serpin synthesis by the trophoblast and/or by the ation of the inhibitors released by trophoblast. (Pediatr endometrium could be associated with spontaneous abortion, Res 34: 312-317,1993) gestational trophoblastic disease, and abnormal development of the placenta. Abbreviations Recently, Earl et al. (8) demonstrated immunohistochemically the presence of al-AT and aI-ACHY in early, term, and ectopic al-AT, I-antitrypsin trophoblastic tissue. The cytoplasmic localization of these proal-ACHY, al-antichymotrypsin tease inhibitors suggested trophoblastic synthesis as opposed to CBG, corticosteroid-binding globulin passive absorption from maternal blood. However, these authors FBS, fetal bovine serum did not provide unequivocal evidence for their synthesis by the DMEM, Dulbecco's modified Eagle media placenta. The study described herein was undertaken to provide PNGase F, peptide-N-glycosidase F evidence for placental synthesis of aI-AT and al-ACHY. To this hCG, human chorionic gonadotropin end, 1 ) messenger RNA for al-AT and aI-ACHY was identified in first-trimester and term chorionic villi and in human trophoblast cells in primary culture and 2) after metabolic labeling of cultured trophoblast cells with [35S]-methionine, [3SS]-labeled a l -AT and a!-ACHY protein was found in the spent media. It may a,-AT and a,-ACHY are closely related glycoprotein protease be significant that the aI-AT and aI-ACHY released by trophoinhibitors present in plasma and extracellular fluids that neutral-blast are not glycosylated to the same extent as the aI-AT and ize serine proteases through the formation of stable 1: I complexes al-ACHY found in plasma. Prirnary trophoblast cztltures. Trophoblast cells were isolated from term placentas by a modification of the methods described by Bax et a/. (9) and Kliman et a/.
(1 0). Fresh placentas, delivered either vaginally or by cesarean section, were dissected to remove the basal plate. Cotyledons were removed, cut into approximately 4-cm3 pieces, washed three times with wash buffer (PBS with 5.5 m M glucose, 0.33 m M sodium pyruvate, 20 U/mL heparin, and antibiotics), and then incubated in wash buffer without heparin for 20 rnin with gentle shaking at 37°C. The tissue fragments were further dissected into 1-cm3 pieces and incubated in digestion buffer (PBS with 5.5 m M glucose, 0.33 m M sodium pyruvate, 2 mg/mL pancreatin, and 0.25 pg/mL trypsin) for 20-30 min with gentle shaking at 37°C. The digestion buffer was decanted and the digestion process repeated. The digestion mixture was vigorously shaken for 30 s and filtered first through a single layer of sterile gauze, then through two layers, then through three layers. The cells were pelleted by centrifugation and purified by centrifugation through a 50-mL 5-70% Percoll gradient (30 min, 1200 x g, room temperature). The trophoblast-containing layer was removed from the gradient, and the trophoblast cells were washed three times with serum-free medium and plated at 2 X lo5 cells/cm2 on Plastek C culture plates (Mattek, Ashland, MA) in medium 199 containing 15% FBS and antibiotics. This procedure yielded a cell population that in these experiments was >95% trophoblast as determined by immunofluorescence with antibodies to the following antigens: cytokeratin (trophoblast), vimentin (fibroblast), and HLA-DR (macrophages). Cells were used 72 h after plating, at which time trophoblast had differentiated into a syncytia-like monolayer resembling trophoblast in viro.
Trophoblast cells were isolated from first trimester placentas using a modification of the method described by Fisher ct al.
(1 1). Placental tissue obtained by vaginal aspiration from interrupted pregnancies after 8-15 wk gestation was washed in PBS containing antibiotics, 5.5 m M glucose, 0.33 m M sodium pyruvate and 20 U/mL heparin. Chorionic villi were dissected free and incubated for 10-20 rnin at 37°C in PBS containing 500 U/mL collagenase, 200 U/mL hyaluronidase, 0.2 mg/mL DNase I, and 1 mg/mL BSA. At the first sign of disintegration (after 10-15 rnin), the villi suspension was centrifuged and the pellet collected. The pellet was resuspended and incubated for 10-20 rnin in PBS containing 0.25 pg/mL trypsin and 2 m M EDTA. Trophoblast cells were isolated by centrifugation through a Percoll gradient and plated as described above.
a I -A T and aI-ACHY sjnthesis by troplzohlast cells in clrltlrre. Primary trophoblast cultures in six-well (35-mm diameter) plates were washed three times with methionine-free DMEM media (without FBS) for 60 rnin and then incubated with fresh DMEM media (without FBS) containing ["SI-methionine (400 pCi/mL) for 6 h. The conditioned medium was centrifuged and the supernatant heated to 100°C and stored at -20°C until used for immunoprecipitation of extracellular proteins. T o determine RNA levels, cells were grown in an analogous fashion but without ["S]-methionine. At the completion of the experiment, the medium was decanted and the cells were lysed in homogenization buffer containing guanidine isothiocyanate.
Erzq~tnutic degl~ros~~latiot~. Aliquots of spent medium (in 0.1 M NaP04, 10 m M EDTA. 10 m M P-mercaptoethanol, pH 7.0, containing0.2% SDS) were heated at 95°C for 10 min to denature glycosylated proteins. After cooling, the reaction mixture was brought to 1% Triton X-100 and incubated with 5 or 10 U/mL of PNGase F at 37°C for 24 h to deglycosylate N-glycoproteins as described in the manufacturer's instructions.
Ir~itnzrrzoprc~cipitatiot~. Aliquots of spent medium were brought to 0.2% in SDS and heated for 2 rnin at 95°C. Nonspecific rabbit IgG (10 pg/mL spent media) was added and the reaction was incubated for 60 rnin at 4°C. Protein A-agarose, as a 50% suspension in buffer A (50 m M Tris-HCI, 150 mM NaCI, 6 m M EDTA, pH 7.4, containing 2.5% Triton X-100). was added and the incubation continued for 60 rnin longer. The Protein A-IgG was removed by centrifugation and four volumes of buffer A was added, followed by antibody to either (YI-AT or a,-ACHY. The incubation was continued overnight at 4°C. Immune complexes were removed with protein A-agarose as above. The beads were washed six times with buffer A and the labeled inhibitors were released by heating to 95°C in sample buffer containing SDS. Labeled inhibitors were then subjected to PAGE in the presence of SDS under reducing conditions. Prestained molecular mass markers were included on all gels. After electrophoresis, labeled proteins on dried gels were visualized by autoradiography.
Isolatiot~ qfrnRNA at~d Northcrn blot analjsis. Total cellular RNA was isolated from chorionic villus material or adherent monolayers of trophoblast cells in primary culture (approximately 10' cells/sample) by guanidine isothiocyanate extraction and centrifugation through a CsCl gradient (12). Plasmids ph-ACT235, containing a full-length human al-ACHY cDNA, and MVR-2, containing a full-length human a I -A T cDNA, were generous gifts from S. Woo (Baylor University, Houston, T X ) and C. Gray (Zymogenetics, Seattle, WA), respectively. A sonicated 2.0-kb human P-actin cDNA probe (pHFPA-I) was a gift from D. Filer (NYU Medical Center, New York, NY). Plasmid DNA was isolated by alkaline extraction, digested with the appropriate restriction endonucleases, and electrophoresed on 1% low melting point agarose gels in TBE buffer (89 mM Tris base. 89 m M boric acid, 2 mM EDTA). Inserts were excised from the gels and purified by phenol/CHCI, extraction followed by ethanol precipitation. Twenty-five ng of each cDNA insert was labeled with [3'P]-deoxycytidine 5' triphosphate using random hexamers as primers (Multiprime DNA Labeling System, Amersham). Unincorporated nucleotides were removed by gel exclusion chromatography (Push Column. Stratagene, La Jolla, CA). Total RNA samples (25-30 pg) were electrophoresed on agarose/formaldehyde gels and transferred to GeneScreen nylon membrane. Blots were hybridized with ["PI-labeled a,-AT and nl-ACHY cDNA under conditions of high stringency (50% formamide. 42°C for 12-18 h) and also washed under conditions of high stringency. After autoradiography, the protease inhibitor cDNA probes were removed and the blots were rehybridized with a ["PI-labeled actin cDNA probe.
RESULTS

E,\-prcssion qfnl-A T and aI-ACHY t?lRNA hj? cllorionic villi.
T o distinguish between placental synthesis of a,-AT and a!-ACHY and contamination by protease inhibitors from the circulation, chorionic villi from first-and third-trimester placentas were examined for the expression nl-AT and nl-ACHY mRNA. Total RNA was prepared from placentas of various gestational ages and analyzed by Northern blotting using [3'P]-labeled human a I -A T and nI-ACHY cDNA probes (Fig. 1) . Sample preparation and hybridization were camed out as described in Methods and Materials. Because the amount of total RNA extracted 3 14 Fig. 1 . Northern blot analysis of total trophoblast RNA from chorionic villi of various gestational ages. RNA was electrophorcscd on 1% agarose/formaldehyde gels, transferred to nylon filters, and hybridized with [12P]-labeled nl-AT or at-ACHY cDNA probes. The filters were then cleared and rehybridized with a "P-labeled @-actin cDNA probe. Gestational ages of the samples were as follows: 1-5. term; 6, 8 wk; 7-9, 10 wk; 10, 1 1 wk; 11 and 12, I2 wk. from each sample depended on the quantity of tissue available for analysis, after the first hybridization the blots were cleared and rehybridized with a [-"PI-labeled @-actin cDNA probe. Relative protease inhibitor mRNA levels in each sample were determined by densitometric scanning of the autoradiograms and normalized for the amount ofactin mRNA (Table I) . In general, all the samples analyzed expressed aI-AT mRNA, with a wide variation among samples. There were similar variations in the expression of at-ACHY mRNA. In some samples, a,-ACHY mRNA was not detected (Table 1, samples 5, 11, 18, 19) . It is possible that these were contaminated by mononuclear cells, which express high levels of a!-AT. The variability in aI-AT and aI-ACHY expression by different placentas is difficult to explain. However, it is consistent with similar interplacental variability in hCG and progesterone secretion as reflected by maternal serum levels. The normal range of hCG and progesterone in maternal serum at 36-40 wk gestation is 2 400-36 000 mIU/mL and 55-255 ng/mL, respectively. No clear-cut pattern emerged relating protease inhibitor levels to gestational age, and because of the relatively small number of samples in this study no conclusions could be drawn.
Expression of aI-AT and a,-ACIIY rnRNA and prolcitl by trophoblast cells in cz(ltttre. Because of the cellular heterogeneity of the placenta, it was necessary to determine whether the observed results represented synthesis by trophoblast or by contaminating fibroblasts or Hofbauer cells. Therefore, we examined the synthesis of aI-AT and aI-ACHY mRNA and protein by trophoblast cells in culture. Trophoblast cells were isolated from placental tissue by protocols that yield a cell population ofgreater 'f Protease inhibitor mRNA levels are normalized with regard to those of actin. than 95% trophoblast (Esterman AL, unpublished observations; 10). Northern blot analysis of total RNA from trophoblast in primary culture obtained from 9-wk and term placenta demonstrated the presence of nl-AT and a,-ACHY mRNA ( Fig. 2A) . As further evidence of the purity of the trophoblast population used in these studies, it should be noted that expression of a,-ACHY by human peripheral monocytes is < I % of that of MCF-7 cells (or trophoblast), whereas expression of al-AT or aI-ACHY by fibroblasts is not detectable by standard Northern blotting techniques (Kadner SS, Banejee S, Cruz MR. Finlay TH, unpublished manuscript).
Synthesis of the specific proteins was investigated using cultured trophoblast cells metabolically labeled with ["SI-methionine. Radiolabeled a,-AT and a,-ACHY were found in conditioned media after immunoprecipitation with polyclonal antibodies to a,-AT and al-ACHY and SDS-PAGE (Fig. 28) . However, the newly synthesized a,-AT and a,-ACHY released by trophoblast cells both appeared to have M, considerably lower than reported for the same proteins secreted by other cell types (1, 3, 5 ). The differences were confirmed when the M, of ."Slabeled a,-AT and a,-ACHY released by trophoblast and HepG2 human hepatoma cells were compared using SDS-PAGE (Fig.  3) . The a,-AT or a,-ACHY synthesized and secreted by trophoblast have M, of 50 000 and 49 000, respectively, whereas the inhibitors secreted by HepG2 cells and MCF-7 human breast cancer cells (data not shown, but see reference 5) demonstrate M, of 54 000 and 68 000. T o verify the identity of the immunoprecipitated proteins from trophoblast, the immunoprecipitation was repeated with and without the addition of unlabeled protease inhibitor (Fig. 4) . In both cases, unlabeled inhibitor blocked the immunoprecipitation of the labeled protein.
Are a ,-,-I T a n d a I -ACII Y relcascd h j~ trop/~ohlu.sr glj~co.sj~lat~~d.'~ T o determine whether the lower M, of the inhibitors released by trophoblast was due to differences in glycosylation or to differences in peptide chain length, the nl-AT or a,-ACHY in the spent media from metabolically labeled trophoblast and HepG2 cells were enzymatically deglycosylated with PNGase F and examined by SDS-PAGE after immunoprecipitation (Fig. 3) . Incubation with PNGase F, which efficiently cleaves the Nglycan linkage between asparagine and carbohydrate chain in denatured glycoproteins (13) , reduced the M, of the nl-AT and a,-ACHY secreted by both trophoblast and HepG2 cells to approximately 46 000, the molecular weight anticipated from the mRNA sequences. In Figure 311 and B, deglycosylation was incomplete, particularly in the case of the HepG2 cell inhibitors. However, the difference between the untreated and treated trophoblast inhibitors is clear. Complete deglycosylation of the HepG2 cell inhibitors was accomplished after incubation with a higher level of PNGase F (Fig. 3C) . The a and fi subunits of hCG immunoprecipitated from this sample with a rabbit polyclonal antibody to hCG had M, of 34000 and 22 000, respectively, suggesting normal glycosylation (data not shown) (14) . These results are consistent with the a,-AT and a,-ACHY released by trophoblast being only partially glycosylated. If the a,-AT and a,-ACHY expressed by trophoblast were incompletely glycosylated, then their transit time through the Golgi apparatus might differ from that in hepatocytes. T o test this possibility, the time course for the appearance of a,-AT and a,-ACHY in the media after pulse labeling with 35S-methionine was compared for trophoblast and HepG2 cells (Fig. 5) . The tv, for release of a,-AT and 0,-ACHY from the HepG2 cells were 50 and 80 min, respectively, which agrees with the results of others (15) . Consistent with the possibility of incomplete glycosylation, the t~, for release of both inhibitors from trophoblast is approximately 25 min.
Cot~lpari.sotl ~f a , -~l T u t~d a,-ACIIY t?rRN,-1 Ji-otn troplroblast mid otlrcr ccll tjpes. a,-AT has been shown to be transcribed from at least four different initiation sites in monocytes, enterocytes, and HcpG2 cells (16, 17) . This results in a series of mRNA of from 1.6 to 2.0 kb, the level of each depending on cell type and degree of up-regulation. T o detcrmine whether synthesis of a,-AT and a,-ACHY mRNA by trophoblast matched the pattern by one of the above cell types, Northern blot analysis was performed on total RNA obtained from trophoblast. HepG2 cells, and MCF-7 cells (Fig. 6) . It is clear that MCF-7 and trophoblast a,-ACHY mRNA have similar mobilities, which are different from that of HepG2 cells. However, although it is difficult to distinguish between the HepG2 cell and trophoblast nl-AT mRNA, they both appear to be smaller than the a l -A T mRNA from MCF-7 cells.
DISCUSSION
The immunohistochemical identification of a,-AT and nl-ACHY in the human placenta has recently been described (18) . The location of these protease inhibitors in syncytial trophoblast but not in cytotrophoblast suggests that they play a role in the regulation of proteolytic activity around the invading component of trophoblastic tissue. However, both a,-AT and a,-ACHY are present at high levels in the blood and have been shown to be synthesized by breast and intestinal epithelial cells, monocytes, and resident macrophages. Thus, it is possible that their prcsence in the placenta results from contamination by proteins derived from the circulation. In addition, many cell types have cell surface receptors able to bind and internalize complexes of a,-AT and a,-ACHY with proteases (so-called serpin-enzyme-complex or SEC receptors) (17) . Although the identification of SEC receptors in the placenta has not yet been reported, it is possible that the prcsence of a,-AT and a,-ACHY antigens in this tissue represents internalization rather than local synthesis because polyclonal antibodies to protease inhibitors can also recognize protease inhibitor-protease complexes. Our objective in this study was to detcrmine whether the a,-AT and a,-ACHY in the placenta resulted, at least in part, from synthesis by trophoblast. Time ( m i n ) Fig. 5 . Comparison of nl-AT and nl-ACHY secretion by trophoblast and HepG2 cells. Cells, in 9.6-cm2 wells, were washed with methioninefree medium and then incubated with this same medium containing 250 pCi/mL "S-methionine for 60 min. Cells were washed with medium containing 1 mM cold methionine, and I mL of medium containing 1 mM methionine was added to each well. At the intervals indicated, levels of a,-AT and nl-ACHY in the medium from individual wells was determined by immunoprecipitation and electrophoresis as described in Materials and Methods. Bands in the autoradiogram were quantitated by densitometry. In each experiment, 100% was taken at the time point showing maximum incorporation.
Using whole tissue as well as cultured trophoblast cells obtained from first-and third-trimester placentas, we demonstrated the presence of a,-AT and al-ACHY mRNA by Northern blot analysis. Consistent with this, culture medium from first-and third-trimester trophoblast grown in the presence of ["SI-methi- onine was found to contain labeled, immunoreactive aI-AT and al-ACHY. These observations provide firm evidence for the synthesis and secretion of aI-AT and aI-ACHY in the placenta. In this respect, trophoblast differs from monocytes, which express very low levels of a,-ACHY and resemble MCF-7 cells (i.c. breast epithelial cells). It is noteworthy that the a,-AT and a l -ACHY secreted by trophoblast have M, of 50 000 and 49 000, respectively, whereas the a,-AT and al-ACHY secreted by hepatocytes, monocytes, and epithelial cells and present in the circulation have M, of 54 000 and 68 000, respectively (I, 3, 5). The circulating forms of a,-AT and nl-ACHY are highly Nglycosylated (13% and 24% carbohydrate in three and four glycan chains, respectively) and the N-glycans are easily removed with PNGase F (19) . Our finding that after deglycosylation the M, of the a,-AT and al-ACHY produced by trophoblast and HepG2 cells all appear to be the same suggests that the lower M, of the inhibitors secreted by the trophoblast results from a reduced level of glycosylation. Although there is no evidence for the existence of more than one peptide sequence for either a,-AT or aI-ACHY in humans, different RNA splicing patterns in trophoblast resulting in altered peptide sequences cannot be ruled out. The relationship between glycosylation and rate of secretion of a l -AT and al-ACHY by trophoblast and HepG2 cells is consistent with the fact that glycosylation patterns are in many instances tissue-specific (20) and that transit time through the Golgi apparatus can increase with increased glycosylation (21) . It is confusing, however, that inhibitors of carbohydrate processing have been shown to retard secretion of a,-AT and a,-ACHY in HepG2 cells (22) . (Y,-AT mRNA has been shown to be transcribed from at least four different initiation sites (16, 17) . This apparently can result in different levels of expression under different conditions of up-regulation in different cell types. It is unclear from our data whether a,-AT transcription in trophoblast follows the hepatocyte or epithelial cell model, although the sizes of the HepG2 and trophoblast mRNA are both smaller than mRNA from MCF-7 cells. Our data suggest that an analogous situation exists for a,-ACHY. In this instance, a,-ACHY mRNA from trophoblast and MCF-7 cells are similar in size and smaller than the mRNA from HepG2 cells.
Serpins such as a,-AT and al-ACHY modulate physiologic responses by inhibiting physiologically active proteases. For a,-AT and aI-ACHY, these are primarily the proteases released by leukocytes at sites of inflammation. It has been proposed that one such protease, polymorphonuclear neutrophil elastase, releases glucocorticoids from CBG and thus al-AT may be involved in the regulation of local glucocorticoid levels. a,-AT and aI-ACHY may also regulate local levels of proteases involved in the activation and release of growth factors, a second feature of the inflammatory response. Possible candidates are an unidentified, elastase-like enzyme that cleaves the 50-amino acid form of transforming growth factor-a from its membrane-bound precursor on the surface of many cell types (23) and a kallikreinlike protease, inhibited by aI-ACHY in vitro, that has been proposed to effect the release of IGF-I from its binding protein (24) . In the rat, serum levels of IGFBP-3, the principal IGF-I binding protein, decrease as pregnancy advances because of such a proteolytic cleavage (25) .
The ability of the trophoblast to regulate its own growth and the maternal inflammatory response may be important for proper implantation as well as continued growth and function of the placenta. It is possible that synthesis of aI-AT and al-ACHY by the invading trophoblast blocks the maternal defense mechanism and facilitates establishment of a normal placenta. Continued production of nl-AT and aI-ACHY may be necessary for modulation of growth factor activity as well as suppression of local inflammation at the decidual cell and vascular interfaces with trophoblast. It may be significant that wide variations in nl-AT and al-ACHY mRNA levels were found among different placentas. Possible correlations between synthesis of nl-AT and a,-ACHY and underlying inflammatory conditions or the existence of infection are presently under investigation. Most intriguing is the possible regulation of this process by serpinlprotease pairs. Because levels of placental proteases appear to vary during pregnancy (23, 24) , protease inhibitors synthesized locally as well as circulating inhibitors produced by the liver may be required for coordinated growth and differentiation of the placenta.
